Hironori Fukuda

Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab

Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo et al. · Urologic Oncology Seminars and Original Investigations · 2019 · 95 citations

Medicine, Immunology, Oncology +14

Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma

Hiroki Ishihara, Hidekazu Tachibana, Toshio Takagi et al. · Targeted Oncology · 2019 · 69 citations

Medicine, Immunology, Oncology +17

Acquired cystic disease‐associated renal cell carcinoma is the most common subtype in long‐term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi‐institutional study

Tsunenori Kondo, Naoto Sasa, Hiroshi Yamada et al. · Pathology International · 2018 · 50 citations · Full text

Medicine, Nephrology, Pathology +17

Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy

Hironori Fukuda, Toshio Takagi, Tsunenori Kondo et al. · Oncotarget · 2018 · 44 citations · Full text

Medicine, Oncology, Urology +16

A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion

Hironori Fukuda, Ikuma Kato, Mitsuko Furuya et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2018 · 37 citations

Medicine, Oncology, Pathology +10